Equities

BBS-Bioactive Bone Substitutes Oyj

BBS-Bioactive Bone Substitutes Oyj

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (EUR)0.38
  • Today's Change0.00 / 0.00%
  • Shares traded16.08k
  • 1 Year change-46.65%
  • Beta0.1640
Data delayed at least 15 minutes, as of May 16 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

BBS-Bioactive Bone Substitutes Oyj (BBS) is a Finland-based company engaged in the medical equipment industry. The Company operates as a biotechnology company that develops and distributes medical device implants used in orthopedic surgery. Its products include ARTEBONE, an orthopedic bone substitute material made from reindeer bone protein matrix made using a propriety patented manufacturing process that can be used in various application areas, such as bone regeneration, healing of fractures, non-unions, bone defect, dental implantation, orthopedics, maxillofacial/dental surgery and osteoporotic fractures.

  • Revenue in EUR (TTM)0.00
  • Net income in EUR-3.48m
  • Incorporated1991
  • Employees--
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
ProstaLund AB1.91m-1.46m4.50m----0.9475--2.36-0.2469-0.24690.32370.72190.38110.50048.84---29.19-29.15-34.28-35.0170.4975.26-76.61-68.942.16-105.990.0235--27.5410.36-53.27--20.35--
iZafe Group AB429.74k-2.81m4.74m7.00--2.79--11.04-0.133-0.1330.02010.07910.1091.242.46714,857.10-71.38-52.17-82.09-69.40-10.99---655.02-487.500.6947--0.1174--149.93-24.79-36.76---41.66--
Inhalation Sciences Sweden AB1.50m-407.41k4.75m8.00--4.27--3.16-0.3575-0.35751.370.85411.120.94655.422,188,000.00-30.46-27.93-43.51-43.8279.7771.13-27.10-48.022.63-3.800.0776--43.5526.3360.87------
Glycorex Transplantation AB (publ)2.57m-2.61m5.75m23.00--1.59--2.23-0.4111-0.41110.40570.59630.37010.3414--1,302,696.00-37.50-11.30-46.16-13.1789.6391.60-101.34-33.241.36-182.380.207---17.04-2.15-254.06---0.5593--
Kontigo Care AB2.49m18.04k5.78m10.00216.271.8816.502.320.00970.00971.201.120.7134--7.15--0.5175-0.42140.7527-0.619566.9666.310.7254-0.5205--2.370.1069--1.8016.95-92.68--44.94--
Observe Medical ASA-8.60bn-8.60bn7.54m----0.334----------1.38-----------31.10---51.60--33.76---274.820.0711--0.3526---18.80150.54-93.01--25.73--
Redsense Medical AB (publ)2.14m-387.57k7.60m5.00--3.83--3.54-0.3214-0.32141.781.640.87248.186.324,993,400.00-15.77-18.66-17.96-20.9952.7069.02-18.08-46.283.49--0.00--74.1128.9448.47---23.62--
BBS-Bioactive Bone Substitutes Oyj0.00-3.48m7.71m----1.44-----0.2926-0.29260.000.26470.00-------32.71-25.12-38.23-28.54-----------28.790.482-------12.64------
Luxbright AB-40.08k-1.98m8.16m----2.02-----0.3717-0.3717-0.00680.5101-0.0103-------50.99-52.69-53.38-60.37-------2,130.96----0.0044--67.10--38.77------
ScandiDos AB5.59m-416.60k8.91m34.00--2.40--1.59-0.1063-0.10631.430.75880.95730.47877.39---7.14-13.82-13.39-23.9582.5482.49-7.45-17.090.4511-2.630.00--6.704.01-24.27--4.18--
Clinical Laserthermia Systems AB710.48k-6.85m9.11m7.00--2.15--12.82-23.38-23.382.006.290.154310.954.20---150.84-123.49-292.98-312.95-508.29-1,084.16-977.58-1,625.031.50-5.240.0103--31.9935.55-12.92--18.61--
Episurf Medical AB953.26k-7.91m9.11m25.00--1.65--9.56-0.3449-0.34490.04160.24110.086--5.29396,428.60-71.42-47.46-81.48-52.01-----830.63-1,019.292.54--0.068--53.6219.78-22.64---0.4158--
Ortivus AB6.71m-1.77m9.82m42.00--7.11--1.46-0.4655-0.46551.760.35291.003.364.761,953,650.00-26.44-2.41-51.70-4.6333.8842.46-26.39-1.770.5256--0.4544---19.5510.00-409.66--67.43--
Dignitana AB7.39m-1.49m10.03m27.00--14.07--1.36-0.2329-0.23291.150.10311.664.3515.073,187,519.00-33.59-42.21-74.20-68.9168.5266.09-20.17-57.290.4633-6.820.7245--17.9020.5922.52---15.31--
Nanexa AB2.48m-6.06m10.26m19.00--1.28--4.13-0.8143-0.81430.32520.68540.2069-33.452.261,521,474.00-50.54-40.77-66.82-48.77124.7077.27-244.28-532.262.14--0.0193--925.42147.00-30.44--39.10--
BibbInstruments AB0.00-942.01k10.57m----3.94-----0.4379-0.43790.001.180.00-------32.19-39.57-34.83-42.71--59.36---8,032.404.67----------2.72---1.94--
Data as of May 16 2024. Currency figures normalised to BBS-Bioactive Bone Substitutes Oyj's reporting currency: Euro EUR
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.